Role of CXCL13 in asthma: Novel therapeutic target

Chest

Volumn 141, Issue 4, 2012, Pages 886-894

  Baay Guzman, Guillermina Juliana ^a   Huerta Yepez, Sara ^a   Vega, Mario I ^b   Aguilar Leon, Diana ^c   Campillos, Monica ^d   Blake, Jonathon ^d   Benes, Vladimir ^d   Hernandez Pando, Rogelio ^c   Teran, Luis M ^e  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^e INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; IMMUNOGLOBULIN E; MESSENGER RNA;

ADULT; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BRONCHIAL ASSOCIATED LYMPHOID TISSUE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; NEUTROPHIL COUNT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPUTUM;

EID: 84859516029     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0633     Document Type: Article

References (30)

1. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355(21):2226-2235. (Pubitemid 44791164)
2. Bousquet PJ, Chatzi L, Jarvis D, Burney P. Assessing skin prick tests reliability in ECRHS-I. Allergy. 2008;63(3):341-346. (Pubitemid 351224678)
3. Dente FL, Bacci E, Bartoli ML, et al. Magnitude of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patients. Ann Allergy Asthma Immunol. 2008;100(5):457-462. (Pubitemid 351668782)
4. Teran LM, Carroll MP, Shute JK, Holgate ST. Interleukin 5 release into asthmatic airways 4 and 24 hours after endobronchial allergen challenge: its relationship with eosinophil recruitment. Cytokine. 1999;1(7):518-522. (Pubitemid 29317415)
5. Woodfolk JA. T-cell responses to allergens. J Allergy Clin Immunol. 2007;119(2):280-294. (Pubitemid 46204819)
6. Teran LM. CCL chemokines and asthma. Immunol Today. 2000;2(5):235-242. (Pubitemid 30259029)
7. Flood-Page P, Swenson C, Faiferman I, et al International Mepolizumab Study Group. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med. 2007;176(11):1062- 1071. (Pubitemid 350223751)
8. O'Byrne PM. Cytokines or their antagonists for the treatment of asthma. Chest. 2006;130(1):244-250. (Pubitemid 44116867)
9. Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 1996;87(6):1037-1047. (Pubitemid 26427987)
10. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 1998;39(6669):799-803. (Pubitemid 28099679)
11. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med. 1998;187(4):655-660. (Pubitemid 28093368)
12. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med. 1999;190(8):1123-1134. (Pubitemid 29496505)
13. Okada T, Ngo VN, Ekland EH, et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med. 2002;196(1):65-75. (Pubitemid 34747312)
14. Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, Kusser K, Randall TD. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci U S A. 2007;104(25):10577-10582. (Pubitemid 47185707)
15. Wu X, Ghimbovschi S, Aujla PK, Rose MC, Peña MT. Expression profiling of inflammatory mediators in pediatric sinus mucosa. Arch Otolaryngol Head Neck Surg. 2009;135(1):65-72.
16. Patadia M, Dixon J, Conley D, et al. Evaluation of the presence of B-cell attractant chemokines in chronic rhinosinusitis. Am J Rhinol Allergy. 2010;24(1):11-16.
17. Fulkerson PC, Zimmermann N, Hassman LM, Finkelman FD, Rothenberg ME. Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-gamma. J Immunol. 2004;173(12):7565-7574. (Pubitemid 39628198)
18. Huerta-Yepez S, Baay-Guzman GJ, Garcia-Zepeda R, et al. 2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model. Clin Immunol. 2008;129(2):313-324.
19. Negrete-García MC, Velazquez JR, Popoca-Coyotl A, Montes-Vizuet AR, Juárez-Carvajal E, Teran LM. Chemokine (C-X-C motif) ligand 12/stromal cell-derived factor-1 is associated with leukocyte recruitment in asthma. Chest. 2010;138(1):100-106.
20. Godina-Gonzalez S, Furuzawa-Carballeda J, Utrera-Barillas D, et al. Amebic monocyte locomotion inhibitory factor peptide ameliorates inflammation in CIA mouse model by downregulation of cell adhesion, inflammation/chemotaxis, and matrix metalloproteinases genes. Inflamm Res. 2010;59(12):1041-1051.
21. Montes-Vizuet R, Vega-Miranda A, Valencia-Maqueda E, Negrete- García MC, Velásquez JR, Teran LM. CC chemokine ligand 1 is released into the airways of atopic asthmatics. Eur Respir J. 2006;28(1):59-67. (Pubitemid 44914261)
22. Ueda T, Niimi A, Matsumoto H, et al. Role of small airways in asthma: investigation using high-resolution computed tomography. J Allergy Clin Immunol. 2006;118(5):1019-1025. (Pubitemid 44666982)
23. Arnold CN, Campbell DJ, Lipp M, Butcher EC. The germinal center response is impaired in the absence of T cell-expressed CXCR5. Eur J Immunol. 2007;37(1):100-109. (Pubitemid 46128790)
24. Haynes NM, Allen CD, Lesley R, Ansel KM, Killeen N, Cyster JG. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol. 2007;179(8):5099-5108.
25. Hardtke S, Ohl L, Förster R. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood. 2005;106(6):1924-1931. (Pubitemid 41291702)
26. Campbell DJ, Kim CH, Butcher EC. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat Immunol. 2001;2(9):876-881.
27. Kim CH, Rott LS, Clark-Lewis I, Campbell DJ, Wu L, Butcher EC. Subspecialization of CXCR51 T cells: B helper activity is focused in a germinal center-localized subset of CXCR51 T cells. J Exp Med. 2001;193(12):1373-1381. (Pubitemid 32565966)
28. Breitfeld D, Ohl L, Kremmer E, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med. 2000;192(11):1545-1552.
29. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med. 2000;192(11):1553-1562.
30. 13 in children with asthma. J Allergy Clin Immunol. 2007;123(suppl 2):S159.